what are the results of tirzepatide 1 month 4 Weigh-In Update on Semaglutide and tirzepatide work with

Go slow and low The 2024 European Congress on Obesity (ECO) *2 reported on a Danish study involving 2,246 patients, finding that those who tapered off semaglutide slowly kept the lost weight off for at least six months

When I started prescribing the GLP-1 agonists for the disease of obesity the very first problem I ran into with my first patient was that of severe hangovers

A meta-analysis revealed that a 2.4 mg dose of semaglutide led to a reduction of 12.4 kg of body weight, while doses of 3.0 mg of liraglutide, 1.0 mg of semaglutide, and 1.8 mg of liraglutide led to reductions in body weight of 5.2 kg, 3.7 kg, and 1.8 kg, respectively

Cost-effectiveness of weight-management pharmacotherapies in Canada: a societal perspective

Knowing about these symptoms and talking openly with your doctor can help you manage your health while on GLP-1 meds

Indeed, long-acting octreotide (intramuscularly) might offer the potential advantage of less frequent injections that are more convenient for the patient and might reduce injection aversion, which was often reported with short-acting octreotide injections (subcutaneously) 1,17